OBIO
Orchestra BioMed Holdings Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$243.12M
P/E Ratio
—
EPS
$-0.95
Beta
0.52
52W High
$5.42
52W Low
$2.20
50-Day MA
$4.23
200-Day MA
$3.85
Dividend Yield
—
Profit Margin
-167.00%
Forward P/E
—
PEG Ratio
—
About Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. The company is headquartered in New Hope, Pennsylvania.
Fundamentals
| Revenue (TTM) | $32.72M |
| Gross Profit (TTM) | $32.55M |
| EBITDA | $-54.63M |
| Operating Margin | -20069.00% |
| Return on Equity | -161.10% |
| Return on Assets | -43.00% |
| Revenue/Share (TTM) | $0.61 |
| Book Value | $0.94 |
| Price-to-Book | 5.90 |
| Price-to-Sales (TTM) | 7.43 |
| EV/Revenue | 5.03 |
| EV/EBITDA | -1.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -87.30% |
| Shares Outstanding | $59.88M |
| Float | $33.55M |
| % Insiders | 26.23% |
| % Institutions | 41.66% |
Historical Volatility
HV 10-Day
71.32%
HV 20-Day
60.20%
HV 30-Day
56.07%
HV 60-Day
54.06%
HV Rank
19.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($12.29 target)
2
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026